Cai S-S, Tao X-W, Long Y, Xia K, Zhang Y
Department of Cardiovascular Medicine, Department of Neonatal Medicine; Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10307. doi: 10.26355/eurrev_202010_23363.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Effect of miR-26a on diabetic rats with myocardial injury by targeting PTEN, by S.-S. Cai, X.-W. Tao, Y. Long, K. Xia, Y. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (3 Suppl): 304-311-DOI: 10.26355/eurrev_201908_18661-PMID: 31389595" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18661.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们要求证明数据和图表原创性的请求，蔡思思、陶雪薇、龙阳、夏柯、张宇发表于《欧洲医学与药理学评论》2019年；23(3增刊):304 - 311 - DOI: 10.26355/eurrev_201908_18661 - PMID: 31389595的“MicroRNA - 26a通过靶向PTEN对糖尿病心肌损伤大鼠的影响”一文已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/18661 。
